Maestro della Fertilità dell'Uovo (Master of Egg Fertility) is the designation given to an unknown artist who worked in Brescia during the second half of the seventeenth & early eighteenth centuries. The term comes from a painting called La Fertilità dell'Uovo (Egg Fertility), which depicts dwarfs, geese, & crabs producing eggs.

Maestro della Fertilità dell'Uovo's identity has yet to be discovered. Some art historians believe it was Cremona's Bernardino Deho (1675-1717), while others believe it was Angelo Esseradts, also known as 'il Fiammingo.'

This master's works frequently include grotesque creatures, such as dwarfs & animals, engaged in various human occupations. The pieces are marked by a severe foreshortening & a general disregard for space.

The actions & reactions of the people & animals in the compositions are disorderly. The compositions are full of strange & grotesque components, making it difficult to follow what is going on. The master's noisy style is a type of "moral zoology." The ludicrous characters may be meant to depict both the craziness of human existence & the vanity & folly of life.

A banner with a mysterious phrase that apparently reveals the composition's subject is frequently included with the artworks. Of a pair of paintings sold at Sotheby’s, one is inscribed Son Capporal Dei Matti Ch osseruo beni patti (I am corporal of the fools that well observes the rules) while the other is inscribed Assai Ben Balla A chi fortuna Suona (he dances well enough who fortune plays for).

Maestro della Fertilità dell'Uovo (Master of the Fertility of the Egg) is the name given to a yet to be identified artist who worked in the second half of the XVII & early XVIII centuries in Brescia. The name is based on a work called La Fertilità dell'Uovo (Fertility of the Egg), which depicts dwarfs, geese & lobsters hatching eggs

Atlassian › TEAM ☎️  240 17-Sep-21c ↑ 965% 👽✨ 

Atlassian › $TEAM › produces software that helps teams work together more efficiently & effectively offering a broad set of easy to deploy & use tools › Jira, Confluence, Bitbucket, Trello.

83% of Fortune 500 companies use Atlassian software products, utilized by more than 212K customers at both large & small organizations, for open teamwork models & autonomous project planning & management that provides an environment for enterprises to experiment & optimize employee experience for frictionless work environments, in a connected vendor ecosystem for easy interaction back & forth & quick response to market signals & connect with customers to deepen relationships via those processes.

As teamwork becomes increasingly digital, investing in a connected enterprise is the clear path forward for 10 million monthly active users who use Atlassian cloud collaboration management tools & help desk solutions to support a variety of collaboration styles & provide standardization to innovate & cut costs. 

Atlassian operates in 4 segments. 1 › subscriptions, term licenses & cloud agreements 2 › annual maintenance contracts that provide support & periodic updates & are generally attached to perpetual license sales. 3 › perpetual license, upfront sale for indefinite usage of the software 4 › other, training, strategic consulting & revenue from the Atlassian Marketplace app store.

What sets Atlassian apart is its first mover advantage in its core market. Given the time sensitive nature & delivery windows of most software projects. Most of Atlassian's customers simply don’t have the appetite for risking project execution nor the time to adopt a new platform. This has resulted in creating a moat, as there are indirect costs associated with the learning curve & switching altogether to another platform. 

Atlassian delivers the tools & platforms that developers need to build applications. With every company in every sector becoming a software-driven company, there will be almost infinite demand for new applications. As developers raced to build new applications to help their companies cope with the pandemic, they gravitated toward the tools that enabled them to work the fastest & most efficiently. Every company from the smallest mom & pop shop to the largest multinational realized with utmost clarity that they would live or die by software.

“We are a multi-product company. We differ from many companies that get product/market fit & grow to $500 million in revenue before their second product. We introduced a second product › Confluence, before we reached that scale. We found that customers perceived that software documentation is poor, so we developed a product for document collaboration that’s like a Google Doc on steroids. We have multi-product in our DNA. We now have 14 different products.” — Cameron Deatsch, Chief Revenue Officer

Atlassian applies the now-popular agile systems development mindset to all its operations. 

“As far as process, we use an agile approach. This differs from the traditional waterfall approach in which system requirements are developed over two years & handed off to the systems development people to build. With agile, we start with customer goals & iteratively build versus the goals. Every two weeks we ship something & learn from it. We can apply this approach to marketing, closing the books, & so on. We have daily stand-ups & two week sprints."

Atlassian products meet a unique market need for business customers › modernizing collaboration through human-centered technology, including office productivity tools, video conferencing platforms, file synchronization, sharing solutions, content management apps, etc, empowering companies to design experiences that unlock less fragmented workflows & bring people together in seamless, interconnected & digital experiences.

They are able to land customers at a low cost with little human intervention. In its fiscal Q3 2021, Atlassian brought in 17k new customers who never talked to people at Atlassian or its partners, equating to a robust 9.5% sequential QoQ growth, driven by 5.7k Trello accounts,  as a result of new product features & Atlassian’s sales funnel optimization initiatives.

The addressable market size in total is an estimated $125 billion in terms of potential users, including 800 million knowledge workers at the highest level, drilling down to 100 million technical team members & 23 million software developers. Atlassian noted during the recent industry conference, the company continues to out its online ecosystem, with a marketplace for over 4k apps that utilize its product technology — Forge, which provides runtime for these apps.

Atlassian invents new products through processes propelled by its employees. › it builds on its strengths ⤳ a focus on teams› of which there are many different kinds in different industries › come up with new products by looking at customer use cases & trends outside the norm. Service management is the fastest growing product.

Atlassian continues its strong track record of growth › Q3’21 revenue growing 38% YoY › driven by subscription revenue growth of 43% YoY. Subscription now comprises 62% of TEAM’s total revenue & its recurring nature helps to smooth out the revenue stream › resulting in higher predictability.

Atlassian has grown impressively over the past few years because it adopts a low-cost web-based marketing & lean transactional operating model › going without a traditional enterprise salesforce & marketing team. Atlassian has a large opportunity ahead › demonstrating strong profitability relative to peers › with a gross profit margin of 84% › far higher than the 49% sector average › a strong balance sheet & plenty of cash to fund future growth initiatives › its FCF margin is 43% › comparing favorably to 12.6% sector median. 

Given the subscription-heavy nature of the business › Atlassian's revenue stream has resulted in sequential quarterly revenue growth over at least the past 3 years & this includes pandemic quarters. Atlassian stopped new sales of server license › increased pricing & created pull-forward effects that incentivize users to renew early › leading to strong revenue & billings growth. Atlassian has demonstrated impressive revenue growth since its IPO in 2015 › growing by 513% over this timeframe to $1.96 billion for the trailing 12 months. Atlassian maintains a fortress balance sheet to fund growth initiatives › with $1.56 billion in cash & short-term investments › no long-term debt › and just $206M in capital leases.

15-Sep-21 › TEAM has outperformed the market in the last year with a price return of ↑ 133.7% while the SPY ETF gained ↑ 34%. TEAM has also outperformed the stock market ETF in the last 3 month & 2 week periods returning ↑ 57.3% & ↑ 7.5% › respectively › SPY returned ↑ 5.6% & ↓ 0.8%. Last quarter › Atlassian reported $560 million in Revenue & $.24 earnings per share › this beat revenue expectation by $35 million & exceeded earnings estimates by $.06.

Potential for competition from legacy software provider Microsoft › MSFT › in the space in which TEAM operates. Atlassian will directly compete against ServiceNow › NOW › as it encroaches on the service desk space. Atlassian’s formal planning processes are adjusted so it can adapt to new threats or opportunities. That’s what happened last year when a competitor’s IPO gave it extra capital to spend on marketing to Atlassian’s customers. Atlassian reprioritized go-to-market resources to keep customer acquisition up in light of that competitor’s spending. One product leader got less. They have OKRs & they adjust.

The reason usually for companies like $TEAM to morph overnight is that they operate in a fast-changing environment & one should not be expected to predict what the stock is going to be worth in 6 months › because 6 months suddenly feels like 6 minutes › that may be true.

Also what's true is that once a $TEAM is established › or committed to a line of attack › it must remain in a state of pure possibility. A Bloomberg terminal recently pointed out what must be one of the purest examples of pure possibility › a management software company called Atlassian. Atlassian is smaller than its software cousins. It has a market capitalization of 97.4 billion. Still it stock price has soared-up more than two-fold to 394.5 since last year.

What distinguishes Atlassian is the spirit in which it doesn't have to do anything. The mere fact that Atlassian is a public company › with the share price that goes up everyday › apparently makes it desirable to an investor that wants to avoid the hassle & the wait involved in cycles of steady growth. Atlassian offers itself as a kind of supernatural bandwagon › albeit one that resembles a spacecraft & without wheels.

This is the beauty of Atlassian. by doing nothing › it has avoided ruling out the possibility of not doing something else. It's list of possible ventures includes › but not limited to › high tech › supernatural resources & communications › r&d › icenses › maintenance › consulting & all software related industries › leaves itself open to so many opportunities & of course there aren't any risks here. it has extremely unlimited assets & sources of revenue. 

But the most telling passage of the possibility-disclosure section in Atlassian's confessional is the one that describes, incredibly, the dangers competitors face. You might think that Atlassian does nothing, & which is something looking to be ironically stated › would have the field to itself › but no › as the beautiful company website explains › 

G’day, we’re Atlassian. We make tools like Jira & Trello that are used by thousands of teams worldwide. & we’re serious about creating amazing products, practices, & open work for all teams.

This article was written by Dogefather's protégé › who ascertains as a result of research › to provide thorough › readable › analysis. His trading strategy is Long only › value › growth › with a medium to long-term horizon. He is generally wary of tech stocks › as this sector is ripe for disruption. However › due to Atlassian's steady predictability & rapidly growing revenues › he aggressively solicits a posture of Atlassian long game › as one can make room in a portfolio for tech companies that are the disruptors that carry a moat. 

📈 🐍 x 49 𝑥¯ 2.15m v.s. 📉 🪡🐁 x 3 𝑥¯ 282k = ↑🐍

a boy brings his pet viper to work which intrigues some of his team but frightens others. 

A certain sense of futility arose within $TEAM shorts when a date was determined in which the moon came down & bounced upon us all

The clinical-stage biotech Ocugen OCGN announced its cell therapy platform technology, NeoCart, on Tuesday after the FDA awarded the Regenerative Medicine Advanced Therapy (RMAT) designation for the program in the repair of knee cartilage lesions in adults.

NeoCart is a three-dimensional tissue-engineered cartilage disc designed to support healing and reduce pain by restoring a patient’s damaged knee cartilage.

The company has engaged the agency to finalize the Phase 3 protocols to drive the clinical development of NeoCart for regulatory authorization.

RMAT allows sponsor companies to secure the benefits of FDA’s fast track and breakthrough therapy designation programs.

Noting the designation an important regulatory milestone for the company, Ocugen's Chief Executive Shankar Musunuri noted, "We view this product as an enabling technology in cell and regenerative therapy for orthopedic indications"

NeoCart® (autologous chondrocyte-derived neocartilage) receives regulatory designation intended to help expedite development of new regenerative medicines

Ocugen Introduces New Cell Therapy Program after FDA Designation

The FDA has lifted the clinical hold on Ocugen OCGN's Phase 2/3 trial, OCU-002, for Covaxin (BBV152), a whole virus inactivated COVID-19 vaccine candidate. 

OCGN stock is down 2% despite the news that clears the biotechnology company to proceed with the necessary clearances for its Covid-19 vaccine. In April, the agency paused trials of Ocugen's vaccine candidate, called Covaxin, after a World Health Organization inspection of a Bharat Biotech facility.

It appears Bharat has resolved those issues, which is a positive development for Ocugen & its shareholders.

In a news release, Dr. Shankar Musunuri, chairman & co-founder of Ocugen said, "We're extremely pleased that we can proceed with our clinical trials for Covaxin. The need for delivering an additional, differentiated vaccine option, we believe, remains a priority."

Ocugen is responsible for conducting clinical trials & commercializing the Covid-19 vaccine in the U.S. under its partnership with Bharat Biotech. Covaxin already has full approval in India. Globally, Ocugen says 350 million doses of Covaxin have been administered.

Covaxin also has emergency-use authorization in 25 other countries. The vaccine is not yet approved in the United States or Canada.

Today's news that the FDA has cleared Ocugen to once again proceed with clinical trials for its Covid-19 vaccine is a positive development. The Malvern, Pennsylvania-based company's vaccine candidate has suffered from repeated delays & is late to come to market.

Prior to Covid-19, Ocugen was primarily focused on developing treatments for eye disease. It pivoted to developing a vaccine against Covid-19 in partnership with Bharat Biotech in an effort to capitalize on offering a solution to the global health crisis. However, the delay in bringing the Covid-19 vaccine to market has hurt Ocugen's share price.

Year to date, OCGN stock is down 50% & currently trading at just $2.16 a share. At various times, Ocugen has been treated as a meme stock & its share price has jumped as high as $18 before collapsing again.

OCGN stock gets a bounce today on news that it can again resume its clinical trials. Be patient, the company's Covid-19 vaccine will receive full approval in the U.S. & Canada, but it is likely to remain a penny stock should there be any further delays or setbacks.

NeoCart (autologous chondrocyte-derived neocartilage) receives regulatory designation intended to help expedite development of new regenerative medicines. If NeoCart is successful in its phase 3 trial for knee injury other indications should follow quickly & with much less cost.

OCGN Bagholder position: $7.5 19 Jan 24 C x 117 + 2,315 shares @ $9.36

FDA Removes Clinical Hold On Ocugen's COVID Vaccine Trial

OCGN Stock Falls Despite Positive FDA Update

NeoCart is an innovative 3-D platform technology that has been developed over a 21 year period. Weight-bearing Hyaline cartilage is a durable tissue that is found on many joint surfaces including hips, knees, ankles & shoulders. NeoCart is designed to use the bodies own abilities to regrow cartilage quickly & with less pain. 

I believe the market has not factored in the potential revenue from other indications such as ankles, hips & shoulders. If NeoCart is successful in its phase 3 trial for knee injury other indications should follow quickly & with much less cost.

NeoCart® (autologous chondrocyte-derived neocartilage) receives regulatory designation intended to help expedite development of new regenerative medicines.

NeoCart®is a three-dimensional tissue-engineered disc of new cartilage that is manufactured by growing chondrocytes  the cells responsible for maintaining cartilage health — derived from the patient on a unique scaffold. NeoCart®has the potential to accelerate healing & reduce pain by rebuilding a patient’s damaged knee cartilage. It treats pain at the source, creating a similar, functional joint surface as it was before the injury. Ultimately, the goal is to prevent a patient’s progression to osteoarthritis. NeoCart®was acquired as a part of Ocugen’s reverse merger with the original developer of the therapy, Histogenics, in 2019.

Knee Cartilage Repair Market Size & Forecast

Knee Cartilage Repair Market size was valued at $3.4 Billion in 2020 & is projected to reach USD 4.97 Billion by 2028, growing at a CAGR of 4.87% from 2021 to 2028. This revenue potential estimates a 5-10% market share of the 150,000 annual microfracture procedures in the USA alone. 

“We’re excited that NeoCart® has received this RMAT designation, an important regulatory milestone, especially as we view this product as an enabling technology in cell & regenerative therapy for orthopedic indications. Our next step will be working with the FDA to construct the Phase 3 program to bring this innovation to this emerging treatment area,” said Dr. Shankar Musunuri, Chairman, CEO, & Co-Founder, Ocugen, Inc. “People living with articular cartilage lesions literally have holes in their knees that are extremely difficult to heal, & without proper treatment, they’re at high risk of getting osteoarthritis. We believe that NeoCart® offers the potential for an innovative new option where treatments in this area are still limited & results are not optimal.”

The Regenerative Medicine Advanced Therapy (RMAT) designation is part of the 21st Century Cures Act. The program was created to expedite the development & review of regenerative medicine therapies intended to treat, modify, reverse or cure a serious condition. Receiving an RMAT designation offers sponsor companies all the benefits of the fast track & breakthrough therapy designation programs, including early interactions with the FDA. Ocugen is working with the FDA to finalize the Phase 3 protocols necessary to advance the clinical development program of NeoCart® required for eventual market authorization.
        
Articular cartilage lesions are a serious & often mobility-limiting condition. When the cartilage is healthy, it makes movement easy, allowing the bones to glide over each other with very little friction, but it can be damaged by injury or normal wear & tear. Cartilage that is damaged can, over time, cause pain & reduce one’s ability to function. Small articular lesions have a limited capacity to self-repair, & full thickness injuries have no ability to naturally heal. There are no blood vessels or nerves to support healing, & as cartilage matures, chondrocytes have limited ability to replicate. Untreated damage eventually can lead to osteoarthritis.

Details of the NeoCart® development program will be shared at a future date.

NeoCart Has The Potential To Become The Standard Of Care For Patients With Knee Cartilage Damage

When the evening is spread out against the sky

Like a patient etherized upon the table. — T.S. Eliot

In every field of human enterprise, it is obvious that most of the achievements—most of the great steps forward have come from individuals—whether they be artistic, psychotic geniuses, saints, revolutionaries, etc. We do not need the evidence of intelligence testing to know conversely that the vast mass of mankind are not highly intelligent, or highly moral, or highly gifted artistically, or highly qualified—to carry out any of the nobler human activities—of course, to jump from that to the conclusion that mankind can be split into two clearly defined groups—a ‘few’ that is excellent & a ‘many’ that is despicable—is idiotic. 

The hierarchies are infinite—the dividing line between the few & the many must run through each individual—not between individuals. None of us are wholly perfect & none wholly imperfect. On the other hand—history—not least in the 21st century in the ‘Anno Domini’ era—shows that society has persistently seen life in terms of a struggle between the few & the many—between ‘us’ & ‘them.’ 

I tried to establish the virtual ‘innocence’ of the many (I couldn't). Degenerates, opportunistic looters, Marxist extremists, racists committed the evil, but this evil is largely—perhaps wholly—the result of a bad education, a mean environment, being orphaned—all factors over which I had no control.

T.S. Eliot's early poem represents an important contribution to this modernization—absurdity coupled with romanticism. When reading the arresting opening line, one immediately encounters a poetic voice that comfortably juxtaposes the most disparate elements—a romantic evening with an anesthetized patient—time to meet & to murder others—comings & goings—to disturb the universe

I lost my business from the looting that occurred on May 30th, 2020 when the Mayor of California ordered the LAPD a stand down mandate during the BLM riots. Scores of opportunists & masked armed looters took advantage, damaging commercial & personal property & engaging in open theft, vandalism, & violent destruction of my property. The total damages were over 1.5 million dollars of designer clothing, sneakers, jewelry, & rare vintage pieces.

The protesters were honoring Melina Abdullah, the lead organizer of Black Lives Matter LA chapter, who led call & response chants of ‘Disrupt White Capitalism.’ a concept she believes is the root cause of police violence in America. Abdullah, who is also a college professor, went on to drop a string of expletives that seemingly foreshadowed what was to come after the rally would end. “F*** the police,” she shouted into the megaphone. “F*** white capitalism. F*** The Grove. F*** 3rd and Fairfax. F*** Beverly Hills.” By nightfall, stores at every shopping district Abdullah mentioned had been vandalized and looted, and several LAPD cruisers in the Fairfax District were set on fire.

By nightfall, stores at every shopping district Abdullah mentioned had been vandalized and looted. Abdullah’s 16-year-old daughter, Thandiwe, also addressed rallygoers. She co-founded the Black Lives Matter Youth Vanguard and has been speaking at local protests for several years. In 2018, she was honored by Time Magazine as one of the most influential teens in the country.

“I know you want to cry, I know you want to tear some shit up,” Thandiwe said. “If you want to set some corporations on fire, you know what? I don’t care about Target burning. I don’t care that capitalism burns. I don’t care that white people in their f***ing office buildings are upset. I don’t care that you can’t go nowhere because you’re stuck in f***ing traffic. I don’t care that you can’t get to your job or your doctor’s appointment or to wherever the f*** you want to go.”

None of my property was covered by insurance, so I have shuttered my doors & dissolved my company.

My property was accessible, cases were ripped, displays pulled down, all in honor of a very deliberate call & response record to loot & destroy 'white spaces of affluence', but the problem cannot be reduced to such politics alone …

My question is, what would it look like to just give cash grants to people (or small business owners in my type of position) instead of having nonprofits be a ‘middle man’? 

I’m asking because I’ve seen how grant funds are spent & tracked & have thought about real life changing work through mutual aid initiatives rather than programs & services that aren’t always relevant to the community. Not a super critical analysis, just thoughts …

I hope you agree with my sentiment. I know some that have worked in the nonprofit sector & one of the biggest complaints about nonprofits is that they often do what makes them ‘feel good’ instead of what produces the greatest impact or best outcome. If giving business owners (who lost everything from the looting) money directly without any service is more impactful than a program or service, that is what we should be advocating for.

That being said the funding entity has to be on board with this as well. Most funding sources (public & private) require or desire a "program" because they are largely paternalistic in nature. This causes a cyclical process …

Nonprofits pitch programs & services because that is what funding sources want. Since funding sources want programs & services, nonprofits hire people with that expertise & viewpoint. Its pretty horrible … 

Some people do come together to work on art & stuff like that … the kind of work I specifically am involved in, but I guess that can also be funded directly without strings attached …

I am an individual, resident & business owner of California's 28th congressional district. In 2015 I launched CRUVOIR (2015-2020) a California corporation conducting business as a high-end designer clothing store on Melrose Avenue in West Hollywood, California

A voxel is a value on a regular grid in three-dimensional space in 3D computer graphics. Voxels, like pixels in a 2D bitmap, do not usually have their position (or coordinates) explicitly stored with their values. Instead, rendering systems deduce a voxel's position based on its proximity to other voxels (i.e., its position in the data structure that makes up a single volumetric image).

Polygons, unlike pixels & voxels, are frequently represented by the coordinates of their vertices (as points). As a result of this distinction, polygons thrive at representing simple 3D structures with a lot of empty or homogeneously filled space, but voxels excel at describing regularly sampled non-homogeneously filled areas.

Voxels are extensively employed in medical & scientific data visualization & analysis. Voxels are used to characterize the resolution of some volumetric displays. A cubic volumetric display, for example, would be able to show 512512512 voxels.

Mari is a freelance voxel artist & 3D designer based in Istanbul

Mad Maraca's Alien Habitats Are Implicitly Articulated in the Intricate Fabric of an Alienated Society

Prior to May 2020, at the center of my social arrangements, my home, I opened my multi-million dollar mansion in sunset plaza to a friend who was also Black & from the hood of Charlotte, North Carolina. He asked me if I could help him, which meant take him in to live with me & employ him full-time.

At the time, he was living with his uncle in south central LA & was fed up with being impoverished working for Chic-fil-A while trying to pursue a career as a recording artist. I said yes.

Bambizilla lived with me for a full year after that. I enabled him to get more studio time & naturally his music rendered more technological developments.

This point is made only to emphasize the intrinsic relation between my own enterprise & ‘disrupting the status quo of the art world by uplifting emerging Black artists’, each of which express totally differentiated imagined ideas of emancipation in the totality of self-valorizing value.

It is only at the level of appearances that ‘white privilege’ displaces the actual civic work I’ve done

Archive

Tags